Regeneron (REGN) Tops Q3 EPS by 33c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- UBS Reiterates Buy Rating on Snowflake Inc. (SNOW)
Regeneron Reports Third Quarter 2015 Financial and Operating Results
November 4, 2015 6:30 AM ESTTARRYTOWN, N.Y., Nov. 4, 2015 /PRNewswire/ --Â Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)Â today announced financial results for the third quarter of 2015 and provided an update on development programs.
Financial Highlights
($ in millions, except per share data)
Three Months... More
